Cancer Stem Cells Protect Non‐Stem Cells From Anoikis: Bystander Effects

Cancer stem cells (CSCs) are capable of initiation and metastasis of tumors. Therefore, understanding the biology of CSCs and the interaction between CSCs and their counterpart non‐stem cells is crucial for developing a novel cancer therapy. We used CSC‐like and non‐stem breast cancer MDA‐MB‐231 and MDA‐MB‐453 cells to investigate mammosphere formation. We investigated the role of the epithelial cadherin (E‐cadherin)‐extracellular signal‐regulated kinase (Erk) axis in anoikis. Data from E‐cadherin small hairpin RNA assay and mitogen‐activated protein kinase kinase (MEK) inhibitor study show that activation of Erk, but not modulation of E‐cadherin level, may play an important role in anoikis resistance. Next, the two cell subtypes were mixed and the interaction between them during mammosphere culture and xenograft tumor formation was investigated. Unlike CSC‐like cells, increased secretion of interleukin‐6 (IL‐6) and growth‐related oncogene (Gro) chemokines was detected during mammosphere culture in non‐stem cells. Similar results were observed in mixed cells. Interestingly, CSC‐like cells protected non‐stem cells from anoikis and promoted tumor growth. Our results suggest bystander effects between CSC‐like cells and non‐stem cells. J. Cell. Biochem. 117: 2289–2301, 2016. © 2016 Wiley Periodicals, Inc.

[1]  I. Weissman,et al.  Normal and Neoplastic Stem Cells , 2017, Cold Spring Harbor symposia on quantitative biology.

[2]  N. Wong,et al.  Hepatocellular carcinoma-derived exosomes promote motility of immortalized hepatocyte through transfer of oncogenic proteins and RNAs. , 2015, Carcinogenesis.

[3]  R. Janknecht,et al.  Exosome-mediated microRNA signaling from breast cancer cells is altered by the anti-angiogenesis agent docosahexaenoic acid (DHA) , 2015, Molecular Cancer.

[4]  M. Oikawa,et al.  Target irradiation induced bystander effects between stem-like and non stem-like cancer cells. , 2015, Mutation research.

[5]  Klaus Pantel,et al.  Biology, detection, and clinical implications of circulating tumor cells , 2014, EMBO molecular medicine.

[6]  T. Hei,et al.  Radiation-induced glioblastoma signaling cascade regulates viability, apoptosis and differentiation of neural stem cells (NSC) , 2014, Apoptosis.

[7]  G. Calin,et al.  Exosomes as divine messengers: are they the Hermes of modern molecular oncology? , 2014, Cell Death and Differentiation.

[8]  M. Lisanti,et al.  Co-ordination of cell cycle, migration and stem cell-like activity in breast cancer , 2014, Oncotarget.

[9]  L. O’Driscoll,et al.  Exosomes Are Involved in Mediating Radiation Induced Bystander Signaling in Human Keratinocyte Cells , 2014, Radiation research.

[10]  Ji-Seon Lee,et al.  Loss of E-cadherin activates EGFR-MEK/ERK signaling, which promotes invasion via the ZEB1/MMP2 axis in non-small cell lung cancer , 2013, Oncotarget.

[11]  W. Ding,et al.  Intercellular Communication by Exosome-Derived microRNAs in Cancer , 2013, International journal of molecular sciences.

[12]  Sanjun Shi,et al.  Cancer stem cells: therapeutic implications and perspectives in cancer therapy , 2013 .

[13]  Y. Kwon,et al.  Role of the IL-6-JAK1-STAT3-Oct-4 pathway in the conversion of non-stem cancer cells into cancer stem-like cells. , 2013, Cellular signalling.

[14]  Y. Kwon,et al.  Molecular characteristics of cancer stem-like cells derived from human breast cancer cells. , 2013, Anticancer research.

[15]  M. Nieto,et al.  Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1. , 2012, Cancer cell.

[16]  Jing Yang,et al.  Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis. , 2012, Cancer cell.

[17]  J. Bartek,et al.  IL1- and TGFβ-Nox4 signaling, oxidative stress and DNA damage response are shared features of replicative, oncogene-induced, and drug-induced paracrine ‘Bystander senescence’ , 2012, Aging.

[18]  E. Prochownik,et al.  Breast Cancer Stem Cell-Like Cells Are More Sensitive to Ionizing Radiation than Non-Stem Cells: Role of ATM , 2012, PloS one.

[19]  Elizabeth Iorns,et al.  A New Mouse Model for the Study of Human Breast Cancer Metastasis , 2012, PloS one.

[20]  R. Weinberg,et al.  Cancer-stimulated mesenchymal stem cells create a carcinoma stem cell niche via prostaglandin E2 signaling. , 2012, Cancer discovery.

[21]  N. Merchant,et al.  Src-mediated regulation of E-cadherin and EMT in pancreatic cancer. , 2012, Frontiers in bioscience.

[22]  Shan Xu,et al.  E-cadherin promotes proliferation of human ovarian cancer cells in vitro via activating MEK/ERK pathway , 2012, Acta Pharmacologica Sinica.

[23]  Jhi-Joung Wang,et al.  Oct4-related cytokine effects regulate tumorigenic properties of colorectal cancer cells. , 2011, Biochemical and biophysical research communications.

[24]  S. Bicciato,et al.  The Hippo Transducer TAZ Confers Cancer Stem Cell-Related Traits on Breast Cancer Cells , 2011, Cell.

[25]  Max S Wicha,et al.  Breast cancer stem cells, cytokine networks, and the tumor microenvironment. , 2011, The Journal of clinical investigation.

[26]  Robert A. Weinberg,et al.  Tumor Metastasis: Molecular Insights and Evolving Paradigms , 2011, Cell.

[27]  Tao He,et al.  Normal and disease-related biological functions of Twist1 and underlying molecular mechanisms , 2011, Cell Research.

[28]  W. Birchmeier,et al.  E‐cadherin is crucial for embryonic stem cell pluripotency and can replace OCT4 during somatic cell reprogramming , 2011, EMBO reports.

[29]  K. Struhl,et al.  Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion , 2011, Proceedings of the National Academy of Sciences.

[30]  D. Ish-Horowicz,et al.  Cell-autonomous integrin control of Wnt and Notch signalling during somitogenesis , 2010, Development.

[31]  F. Kruyt,et al.  Apoptosis and cancer stem cells: Implications for apoptosis targeted therapy. , 2010, Biochemical pharmacology.

[32]  R. Feng,et al.  Inhibition of epithelial to mesenchymal transition in metastatic breast carcinoma cells by c-Src suppression. , 2010, Acta biochimica et biophysica Sinica.

[33]  E. Prochownik,et al.  Permanently Blocked Stem Cells Derived From Breast Cancer Cell Lines , 2010, Stem cells.

[34]  D. Steindler,et al.  Expression of pluripotent stem cell reprogramming factors by prostate tumor initiating cells. , 2010, The Journal of urology.

[35]  J. Qin,et al.  Migfilin Interacts with Src and Contributes to Cell-Matrix Adhesion-mediated Survival Signaling* , 2009, Journal of Biological Chemistry.

[36]  Sean J Morrison,et al.  Mechanisms of stem cell self-renewal. , 2009, Annual review of cell and developmental biology.

[37]  J. Nör,et al.  Cross talk initiated by endothelial cells enhances migration and inhibits anoikis of squamous cell carcinoma cells through STAT3/Akt/ERK signaling. , 2009, Neoplasia.

[38]  E. Giannoni,et al.  Redox regulation of anoikis resistance of metastatic prostate cancer cells: key role for Src and EGFR-mediated pro-survival signals , 2009, Oncogene.

[39]  Yuh-Lih Chang,et al.  Oct-4 Expression Maintained Cancer Stem-Like Properties in Lung Cancer-Derived CD133-Positive Cells , 2008, PloS one.

[40]  M. Todaro,et al.  Crucial role of interleukin-4 in the survival of colon cancer stem cells. , 2008, Cancer research.

[41]  E. Lander,et al.  Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. , 2008, Cancer research.

[42]  D. Santini,et al.  IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland. , 2007, The Journal of clinical investigation.

[43]  Jos Jonkers,et al.  Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis. , 2006, Cancer cell.

[44]  M. Wicha.  Cancer Stem Cells and Metastasis: Lethal Seeds , 2006, Clinical Cancer Research.

[45]  A. Puisieux,et al.  Metastasis: a question of life or death , 2006, Nature Reviews Cancer.

[46]  K. W. Kim,et al.  Targeting the Akt/mammalian target of rapamycin pathway for radiosensitization of breast cancer , 2006, Molecular Cancer Therapeutics.

[47]  J. Dick,et al.  Cancer stem cells: lessons from leukemia. , 2005, Trends in cell biology.

[48]  J. Paulus,et al.  G1/S Cell Cycle Arrest Provides Anoikis Resistance through Erk-Mediated Bim Suppression , 2005, Molecular and Cellular Biology.

[49]  A. Faussat,et al.  Early Loss of E-cadherin from Cell-Cell Contacts Is Involved in the Onset of Anoikis in Enterocytes* , 2004, Journal of Biological Chemistry.

[50]  V. Rao,et al.  Epidermal Growth Factor Receptor-Dependent Regulation of Integrin-Mediated Signaling and Cell Cycle Entry in Epithelial Cells , 2004, Molecular and Cellular Biology.

[51]  Laurie E Ailles,et al.  Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. , 2004, The New England journal of medicine.

[52]  J. Dick,et al.  Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity , 2004, Nature Immunology.

[53]  C. Jobin,et al.  Down‐regulation of MEK/ERK signaling by E‐cadherin‐dependent PI3K/Akt pathway in differentiating intestinal epithelial cells , 2004, Journal of cellular physiology.

[54]  J. Little,et al.  Stress signaling from irradiated to non-irradiated cells. , 2004, Current cancer drug targets.

[55]  I. Weissman,et al.  Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors. , 2003, Genes & development.

[56]  G. Dontu,et al.  Stem cells in normal breast development and breast cancer , 2003, Breast Cancer Research.

[57]  Dennis C. Sgroi,et al.  Integrins and EGFR coordinately regulate the pro-apoptotic protein Bim to prevent anoikis , 2003, Nature Cell Biology.

[58]  S. Morrison,et al.  Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[59]  I. Macdonald,et al.  Metastasis: Dissemination and growth of cancer cells in metastatic sites , 2002, Nature Reviews Cancer.

[60]  J. Dick,et al.  Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell , 1997, Nature Medicine.

[61]  J. Little,et al.  Induction of sister chromatid exchanges by extremely low doses of alpha-particles. , 1992, Cancer research.

[62]  J. Vieweg,et al.  E-cadherin plasticity in prostate cancer stem cell invasion. , 2011, American journal of cancer research.

[63]  S. Kern,et al.  Ancestral trees for modeling stem cell lineages genetically rather than functionally: understanding mutation accumulation and distinguishing the restrictive cancer stem cell propagation theory and the unrestricted cell propagation theory of human tumorigenesis. , 2008, Breast Disease.

[64]  A. Chambers,et al.  Tumor dormancy and cancer stem cells: implications for the biology and treatment of breast cancer metastasis. , 2006, Breast disease.

[65]  I. Weissman.  Normal and neoplastic stem cells. , 2015, Novartis Foundation symposium.